nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosutinib—STK24—Teniposide—Etoposide—germ cell cancer	0.00248	0.279	CbGdCrCtD
Bosutinib—CASK—Teniposide—Etoposide—germ cell cancer	0.0016	0.18	CbGdCrCtD
Bosutinib—CHEK2—Vindesine—Vinblastine—germ cell cancer	0.00111	0.124	CbGdCrCtD
Bosutinib—ERBB3—Podofilox—Etoposide—germ cell cancer	0.00103	0.116	CbGdCrCtD
Bosutinib—Abdominal discomfort—Cisplatin—germ cell cancer	0.000727	0.00291	CcSEcCtD
Bosutinib—Erythema multiforme—Dactinomycin—germ cell cancer	0.000726	0.00291	CcSEcCtD
Bosutinib—Pancytopenia—Cisplatin—germ cell cancer	0.00072	0.00288	CcSEcCtD
Bosutinib—Discomfort—Vinblastine—germ cell cancer	0.000714	0.00286	CcSEcCtD
Bosutinib—Alanine aminotransferase increased—Etoposide—germ cell cancer	0.000709	0.00284	CcSEcCtD
Bosutinib—Hepatitis—Ifosfamide—germ cell cancer	0.000704	0.00282	CcSEcCtD
Bosutinib—CHEK2—Vinorelbine—Vinblastine—germ cell cancer	0.000697	0.0783	CbGdCrCtD
Bosutinib—CHEK2—Podofilox—Etoposide—germ cell cancer	0.000697	0.0782	CbGdCrCtD
Bosutinib—CHEK2—Teniposide—Etoposide—germ cell cancer	0.000697	0.0782	CbGdCrCtD
Bosutinib—Urinary tract disorder—Ifosfamide—germ cell cancer	0.000695	0.00278	CcSEcCtD
Bosutinib—Connective tissue disorder—Ifosfamide—germ cell cancer	0.000692	0.00277	CcSEcCtD
Bosutinib—Urethral disorder—Ifosfamide—germ cell cancer	0.00069	0.00276	CcSEcCtD
Bosutinib—Thrombocytopenia—Vinblastine—germ cell cancer	0.000678	0.00272	CcSEcCtD
Bosutinib—Respiratory failure—Methotrexate—germ cell cancer	0.000675	0.0027	CcSEcCtD
Bosutinib—Erythema multiforme—Ifosfamide—germ cell cancer	0.000666	0.00266	CcSEcCtD
Bosutinib—Ill-defined disorder—Bleomycin—germ cell cancer	0.000665	0.00266	CcSEcCtD
Bosutinib—Renal failure—Cisplatin—germ cell cancer	0.000664	0.00266	CcSEcCtD
Bosutinib—Anaemia—Bleomycin—germ cell cancer	0.000663	0.00265	CcSEcCtD
Bosutinib—Pancytopenia—Etoposide—germ cell cancer	0.00066	0.00264	CcSEcCtD
Bosutinib—Tinnitus—Ifosfamide—germ cell cancer	0.000656	0.00263	CcSEcCtD
Bosutinib—Cardiac disorder—Ifosfamide—germ cell cancer	0.000653	0.00262	CcSEcCtD
Bosutinib—Neutropenia—Etoposide—germ cell cancer	0.000649	0.0026	CcSEcCtD
Bosutinib—Malaise—Bleomycin—germ cell cancer	0.000647	0.00259	CcSEcCtD
Bosutinib—Leukopenia—Bleomycin—germ cell cancer	0.000642	0.00257	CcSEcCtD
Bosutinib—Hepatobiliary disease—Cisplatin—germ cell cancer	0.000639	0.00256	CcSEcCtD
Bosutinib—Immune system disorder—Ifosfamide—germ cell cancer	0.000636	0.00255	CcSEcCtD
Bosutinib—Mediastinal disorder—Ifosfamide—germ cell cancer	0.000634	0.00254	CcSEcCtD
Bosutinib—Cough—Bleomycin—germ cell cancer	0.000626	0.00251	CcSEcCtD
Bosutinib—Pneumonia—Etoposide—germ cell cancer	0.000623	0.00249	CcSEcCtD
Bosutinib—Ill-defined disorder—Dactinomycin—germ cell cancer	0.00062	0.00248	CcSEcCtD
Bosutinib—Infestation—Etoposide—germ cell cancer	0.000619	0.00248	CcSEcCtD
Bosutinib—Infestation NOS—Etoposide—germ cell cancer	0.000619	0.00248	CcSEcCtD
Bosutinib—Anaemia—Dactinomycin—germ cell cancer	0.000618	0.00247	CcSEcCtD
Bosutinib—Malnutrition—Ifosfamide—germ cell cancer	0.000613	0.00245	CcSEcCtD
Bosutinib—Chest pain—Bleomycin—germ cell cancer	0.00061	0.00244	CcSEcCtD
Bosutinib—Myalgia—Bleomycin—germ cell cancer	0.00061	0.00244	CcSEcCtD
Bosutinib—Renal failure—Etoposide—germ cell cancer	0.000609	0.00244	CcSEcCtD
Bosutinib—Discomfort—Bleomycin—germ cell cancer	0.000603	0.00241	CcSEcCtD
Bosutinib—Malaise—Dactinomycin—germ cell cancer	0.000603	0.00241	CcSEcCtD
Bosutinib—Decreased appetite—Vinblastine—germ cell cancer	0.000602	0.00241	CcSEcCtD
Bosutinib—Urinary tract disorder—Cisplatin—germ cell cancer	0.000599	0.0024	CcSEcCtD
Bosutinib—Leukopenia—Dactinomycin—germ cell cancer	0.000599	0.0024	CcSEcCtD
Bosutinib—Connective tissue disorder—Cisplatin—germ cell cancer	0.000596	0.00239	CcSEcCtD
Bosutinib—CHEK2—Vincristine—Vinblastine—germ cell cancer	0.000596	0.0669	CbGdCrCtD
Bosutinib—Urethral disorder—Cisplatin—germ cell cancer	0.000595	0.00238	CcSEcCtD
Bosutinib—Pain—Vinblastine—germ cell cancer	0.000592	0.00237	CcSEcCtD
Bosutinib—Hepatobiliary disease—Etoposide—germ cell cancer	0.000586	0.00235	CcSEcCtD
Bosutinib—Oedema—Bleomycin—germ cell cancer	0.000585	0.00234	CcSEcCtD
Bosutinib—Anaphylactic shock—Bleomycin—germ cell cancer	0.000585	0.00234	CcSEcCtD
Bosutinib—Infection—Bleomycin—germ cell cancer	0.000581	0.00233	CcSEcCtD
Bosutinib—Agranulocytosis—Etoposide—germ cell cancer	0.000578	0.00231	CcSEcCtD
Bosutinib—Thrombocytopenia—Bleomycin—germ cell cancer	0.000573	0.00229	CcSEcCtD
Bosutinib—Feeling abnormal—Vinblastine—germ cell cancer	0.000571	0.00229	CcSEcCtD
Bosutinib—Myalgia—Dactinomycin—germ cell cancer	0.000569	0.00228	CcSEcCtD
Bosutinib—Ill-defined disorder—Ifosfamide—germ cell cancer	0.000569	0.00228	CcSEcCtD
Bosutinib—Gastrointestinal pain—Vinblastine—germ cell cancer	0.000567	0.00227	CcSEcCtD
Bosutinib—Anaemia—Ifosfamide—germ cell cancer	0.000566	0.00227	CcSEcCtD
Bosutinib—Tinnitus—Cisplatin—germ cell cancer	0.000566	0.00227	CcSEcCtD
Bosutinib—Cardiac disorder—Cisplatin—germ cell cancer	0.000563	0.00225	CcSEcCtD
Bosutinib—Discomfort—Dactinomycin—germ cell cancer	0.000562	0.00225	CcSEcCtD
Bosutinib—Malaise—Ifosfamide—germ cell cancer	0.000553	0.00221	CcSEcCtD
Bosutinib—Urinary tract disorder—Etoposide—germ cell cancer	0.000549	0.0022	CcSEcCtD
Bosutinib—Leukopenia—Ifosfamide—germ cell cancer	0.000548	0.0022	CcSEcCtD
Bosutinib—Immune system disorder—Cisplatin—germ cell cancer	0.000548	0.00219	CcSEcCtD
Bosutinib—Abdominal pain—Vinblastine—germ cell cancer	0.000548	0.00219	CcSEcCtD
Bosutinib—Mediastinal disorder—Cisplatin—germ cell cancer	0.000547	0.00219	CcSEcCtD
Bosutinib—Oedema—Dactinomycin—germ cell cancer	0.000546	0.00219	CcSEcCtD
Bosutinib—Urethral disorder—Etoposide—germ cell cancer	0.000545	0.00218	CcSEcCtD
Bosutinib—Infection—Dactinomycin—germ cell cancer	0.000542	0.00217	CcSEcCtD
Bosutinib—Cough—Ifosfamide—germ cell cancer	0.000535	0.00214	CcSEcCtD
Bosutinib—Thrombocytopenia—Dactinomycin—germ cell cancer	0.000534	0.00214	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.000533	0.00213	CcSEcCtD
Bosutinib—Malnutrition—Cisplatin—germ cell cancer	0.000528	0.00212	CcSEcCtD
Bosutinib—Erythema multiforme—Etoposide—germ cell cancer	0.000526	0.0021	CcSEcCtD
Bosutinib—Dyspnoea—Bleomycin—germ cell cancer	0.000522	0.00209	CcSEcCtD
Bosutinib—Arthralgia—Ifosfamide—germ cell cancer	0.000522	0.00209	CcSEcCtD
Bosutinib—Chest pain—Ifosfamide—germ cell cancer	0.000522	0.00209	CcSEcCtD
Bosutinib—Myalgia—Ifosfamide—germ cell cancer	0.000522	0.00209	CcSEcCtD
Bosutinib—Renal failure acute—Methotrexate—germ cell cancer	0.000521	0.00209	CcSEcCtD
Bosutinib—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000518	0.00207	CcSEcCtD
Bosutinib—Cardiac disorder—Etoposide—germ cell cancer	0.000516	0.00207	CcSEcCtD
Bosutinib—Discomfort—Ifosfamide—germ cell cancer	0.000515	0.00206	CcSEcCtD
Bosutinib—Decreased appetite—Bleomycin—germ cell cancer	0.000509	0.00204	CcSEcCtD
Bosutinib—Immune system disorder—Etoposide—germ cell cancer	0.000502	0.00201	CcSEcCtD
Bosutinib—Mediastinal disorder—Etoposide—germ cell cancer	0.000501	0.00201	CcSEcCtD
Bosutinib—Pain—Bleomycin—germ cell cancer	0.0005	0.002	CcSEcCtD
Bosutinib—Anaphylactic shock—Ifosfamide—germ cell cancer	0.0005	0.002	CcSEcCtD
Bosutinib—Oedema—Ifosfamide—germ cell cancer	0.0005	0.002	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000497	0.00199	CcSEcCtD
Bosutinib—Asthenia—Vinblastine—germ cell cancer	0.000497	0.00199	CcSEcCtD
Bosutinib—Infection—Ifosfamide—germ cell cancer	0.000497	0.00199	CcSEcCtD
Bosutinib—Nervous system disorder—Ifosfamide—germ cell cancer	0.00049	0.00196	CcSEcCtD
Bosutinib—Ill-defined disorder—Cisplatin—germ cell cancer	0.00049	0.00196	CcSEcCtD
Bosutinib—Thrombocytopenia—Ifosfamide—germ cell cancer	0.00049	0.00196	CcSEcCtD
Bosutinib—Anaemia—Cisplatin—germ cell cancer	0.000488	0.00195	CcSEcCtD
Bosutinib—Skin disorder—Ifosfamide—germ cell cancer	0.000486	0.00194	CcSEcCtD
Bosutinib—Feeling abnormal—Bleomycin—germ cell cancer	0.000482	0.00193	CcSEcCtD
Bosutinib—Malaise—Cisplatin—germ cell cancer	0.000476	0.00191	CcSEcCtD
Bosutinib—Decreased appetite—Dactinomycin—germ cell cancer	0.000474	0.0019	CcSEcCtD
Bosutinib—Diarrhoea—Vinblastine—germ cell cancer	0.000474	0.0019	CcSEcCtD
Bosutinib—Dysgeusia—Etoposide—germ cell cancer	0.000474	0.0019	CcSEcCtD
Bosutinib—Leukopenia—Cisplatin—germ cell cancer	0.000473	0.00189	CcSEcCtD
Bosutinib—Fatigue—Dactinomycin—germ cell cancer	0.00047	0.00188	CcSEcCtD
Bosutinib—Back pain—Etoposide—germ cell cancer	0.000468	0.00187	CcSEcCtD
Bosutinib—Pain—Dactinomycin—germ cell cancer	0.000467	0.00187	CcSEcCtD
Bosutinib—Urticaria—Bleomycin—germ cell cancer	0.000465	0.00186	CcSEcCtD
Bosutinib—Body temperature increased—Bleomycin—germ cell cancer	0.000463	0.00185	CcSEcCtD
Bosutinib—Dizziness—Vinblastine—germ cell cancer	0.000458	0.00183	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000456	0.00182	CcSEcCtD
Bosutinib—Myalgia—Cisplatin—germ cell cancer	0.00045	0.0018	CcSEcCtD
Bosutinib—Feeling abnormal—Dactinomycin—germ cell cancer	0.00045	0.0018	CcSEcCtD
Bosutinib—Ill-defined disorder—Etoposide—germ cell cancer	0.000449	0.0018	CcSEcCtD
Bosutinib—Anaemia—Etoposide—germ cell cancer	0.000447	0.00179	CcSEcCtD
Bosutinib—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000447	0.00179	CcSEcCtD
Bosutinib—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000446	0.00179	CcSEcCtD
Bosutinib—Dyspnoea—Ifosfamide—germ cell cancer	0.000446	0.00179	CcSEcCtD
Bosutinib—Discomfort—Cisplatin—germ cell cancer	0.000444	0.00178	CcSEcCtD
Bosutinib—Vomiting—Vinblastine—germ cell cancer	0.00044	0.00176	CcSEcCtD
Bosutinib—Malaise—Etoposide—germ cell cancer	0.000436	0.00175	CcSEcCtD
Bosutinib—Decreased appetite—Ifosfamide—germ cell cancer	0.000435	0.00174	CcSEcCtD
Bosutinib—Headache—Vinblastine—germ cell cancer	0.000434	0.00174	CcSEcCtD
Bosutinib—Leukopenia—Etoposide—germ cell cancer	0.000433	0.00173	CcSEcCtD
Bosutinib—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000432	0.00173	CcSEcCtD
Bosutinib—Abdominal pain—Dactinomycin—germ cell cancer	0.000431	0.00173	CcSEcCtD
Bosutinib—Body temperature increased—Dactinomycin—germ cell cancer	0.000431	0.00173	CcSEcCtD
Bosutinib—Fatigue—Ifosfamide—germ cell cancer	0.000431	0.00173	CcSEcCtD
Bosutinib—Oedema—Cisplatin—germ cell cancer	0.000431	0.00173	CcSEcCtD
Bosutinib—Anaphylactic shock—Cisplatin—germ cell cancer	0.000431	0.00173	CcSEcCtD
Bosutinib—Infection—Cisplatin—germ cell cancer	0.000428	0.00171	CcSEcCtD
Bosutinib—Pain—Ifosfamide—germ cell cancer	0.000428	0.00171	CcSEcCtD
Bosutinib—Nervous system disorder—Cisplatin—germ cell cancer	0.000423	0.00169	CcSEcCtD
Bosutinib—Cough—Etoposide—germ cell cancer	0.000422	0.00169	CcSEcCtD
Bosutinib—Thrombocytopenia—Cisplatin—germ cell cancer	0.000422	0.00169	CcSEcCtD
Bosutinib—Asthenia—Bleomycin—germ cell cancer	0.00042	0.00168	CcSEcCtD
Bosutinib—Skin disorder—Cisplatin—germ cell cancer	0.000419	0.00168	CcSEcCtD
Bosutinib—Pruritus—Bleomycin—germ cell cancer	0.000414	0.00166	CcSEcCtD
Bosutinib—Feeling abnormal—Ifosfamide—germ cell cancer	0.000412	0.00165	CcSEcCtD
Bosutinib—Chest pain—Etoposide—germ cell cancer	0.000412	0.00165	CcSEcCtD
Bosutinib—Nausea—Vinblastine—germ cell cancer	0.000412	0.00165	CcSEcCtD
Bosutinib—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000409	0.00164	CcSEcCtD
Bosutinib—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000409	0.00164	CcSEcCtD
Bosutinib—Discomfort—Etoposide—germ cell cancer	0.000407	0.00163	CcSEcCtD
Bosutinib—Abdominal discomfort—Methotrexate—germ cell cancer	0.000399	0.0016	CcSEcCtD
Bosutinib—Urticaria—Ifosfamide—germ cell cancer	0.000397	0.00159	CcSEcCtD
Bosutinib—Abdominal pain—Ifosfamide—germ cell cancer	0.000395	0.00158	CcSEcCtD
Bosutinib—Body temperature increased—Ifosfamide—germ cell cancer	0.000395	0.00158	CcSEcCtD
Bosutinib—Pancytopenia—Methotrexate—germ cell cancer	0.000395	0.00158	CcSEcCtD
Bosutinib—Anaphylactic shock—Etoposide—germ cell cancer	0.000395	0.00158	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000393	0.00157	CcSEcCtD
Bosutinib—Infection—Etoposide—germ cell cancer	0.000392	0.00157	CcSEcCtD
Bosutinib—Asthenia—Dactinomycin—germ cell cancer	0.000392	0.00157	CcSEcCtD
Bosutinib—Neutropenia—Methotrexate—germ cell cancer	0.000389	0.00156	CcSEcCtD
Bosutinib—Thrombocytopenia—Etoposide—germ cell cancer	0.000387	0.00155	CcSEcCtD
Bosutinib—Upper respiratory tract infection—Methotrexate—germ cell cancer	0.000387	0.00155	CcSEcCtD
Bosutinib—Dyspnoea—Cisplatin—germ cell cancer	0.000384	0.00154	CcSEcCtD
Bosutinib—Skin disorder—Etoposide—germ cell cancer	0.000384	0.00154	CcSEcCtD
Bosutinib—Decreased appetite—Cisplatin—germ cell cancer	0.000375	0.0015	CcSEcCtD
Bosutinib—Diarrhoea—Dactinomycin—germ cell cancer	0.000373	0.0015	CcSEcCtD
Bosutinib—Pneumonia—Methotrexate—germ cell cancer	0.000373	0.00149	CcSEcCtD
Bosutinib—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000372	0.00149	CcSEcCtD
Bosutinib—Vomiting—Bleomycin—germ cell cancer	0.000372	0.00149	CcSEcCtD
Bosutinib—Infestation NOS—Methotrexate—germ cell cancer	0.000371	0.00149	CcSEcCtD
Bosutinib—Infestation—Methotrexate—germ cell cancer	0.000371	0.00149	CcSEcCtD
Bosutinib—Rash—Bleomycin—germ cell cancer	0.000369	0.00148	CcSEcCtD
Bosutinib—Pain—Cisplatin—germ cell cancer	0.000369	0.00148	CcSEcCtD
Bosutinib—Dermatitis—Bleomycin—germ cell cancer	0.000369	0.00148	CcSEcCtD
Bosutinib—Renal failure—Methotrexate—germ cell cancer	0.000365	0.00146	CcSEcCtD
Bosutinib—Asthenia—Ifosfamide—germ cell cancer	0.000359	0.00144	CcSEcCtD
Bosutinib—Feeling abnormal—Cisplatin—germ cell cancer	0.000355	0.00142	CcSEcCtD
Bosutinib—Pruritus—Ifosfamide—germ cell cancer	0.000354	0.00142	CcSEcCtD
Bosutinib—Dyspnoea—Etoposide—germ cell cancer	0.000352	0.00141	CcSEcCtD
Bosutinib—Hepatobiliary disease—Methotrexate—germ cell cancer	0.000351	0.0014	CcSEcCtD
Bosutinib—Nausea—Bleomycin—germ cell cancer	0.000348	0.00139	CcSEcCtD
Bosutinib—Vomiting—Dactinomycin—germ cell cancer	0.000347	0.00139	CcSEcCtD
Bosutinib—Agranulocytosis—Methotrexate—germ cell cancer	0.000346	0.00139	CcSEcCtD
Bosutinib—Rash—Dactinomycin—germ cell cancer	0.000344	0.00138	CcSEcCtD
Bosutinib—Decreased appetite—Etoposide—germ cell cancer	0.000343	0.00137	CcSEcCtD
Bosutinib—Diarrhoea—Ifosfamide—germ cell cancer	0.000342	0.00137	CcSEcCtD
Bosutinib—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000341	0.00137	CcSEcCtD
Bosutinib—Body temperature increased—Cisplatin—germ cell cancer	0.000341	0.00136	CcSEcCtD
Bosutinib—Fatigue—Etoposide—germ cell cancer	0.000341	0.00136	CcSEcCtD
Bosutinib—Pain—Etoposide—germ cell cancer	0.000338	0.00135	CcSEcCtD
Bosutinib—Hepatitis—Methotrexate—germ cell cancer	0.000333	0.00133	CcSEcCtD
Bosutinib—Dizziness—Ifosfamide—germ cell cancer	0.000331	0.00132	CcSEcCtD
Bosutinib—Urinary tract disorder—Methotrexate—germ cell cancer	0.000329	0.00132	CcSEcCtD
Bosutinib—Urethral disorder—Methotrexate—germ cell cancer	0.000326	0.00131	CcSEcCtD
Bosutinib—Feeling abnormal—Etoposide—germ cell cancer	0.000325	0.0013	CcSEcCtD
Bosutinib—Nausea—Dactinomycin—germ cell cancer	0.000324	0.0013	CcSEcCtD
Bosutinib—Gastrointestinal pain—Etoposide—germ cell cancer	0.000323	0.00129	CcSEcCtD
Bosutinib—Vomiting—Ifosfamide—germ cell cancer	0.000318	0.00127	CcSEcCtD
Bosutinib—Rash—Ifosfamide—germ cell cancer	0.000315	0.00126	CcSEcCtD
Bosutinib—Dermatitis—Ifosfamide—germ cell cancer	0.000315	0.00126	CcSEcCtD
Bosutinib—Erythema multiforme—Methotrexate—germ cell cancer	0.000315	0.00126	CcSEcCtD
Bosutinib—Urticaria—Etoposide—germ cell cancer	0.000314	0.00126	CcSEcCtD
Bosutinib—Abdominal pain—Etoposide—germ cell cancer	0.000312	0.00125	CcSEcCtD
Bosutinib—Body temperature increased—Etoposide—germ cell cancer	0.000312	0.00125	CcSEcCtD
Bosutinib—Tinnitus—Methotrexate—germ cell cancer	0.00031	0.00124	CcSEcCtD
Bosutinib—Asthenia—Cisplatin—germ cell cancer	0.000309	0.00124	CcSEcCtD
Bosutinib—Cardiac disorder—Methotrexate—germ cell cancer	0.000309	0.00124	CcSEcCtD
Bosutinib—Immune system disorder—Methotrexate—germ cell cancer	0.000301	0.0012	CcSEcCtD
Bosutinib—Mediastinal disorder—Methotrexate—germ cell cancer	0.0003	0.0012	CcSEcCtD
Bosutinib—Nausea—Ifosfamide—germ cell cancer	0.000297	0.00119	CcSEcCtD
Bosutinib—Diarrhoea—Cisplatin—germ cell cancer	0.000295	0.00118	CcSEcCtD
Bosutinib—Malnutrition—Methotrexate—germ cell cancer	0.00029	0.00116	CcSEcCtD
Bosutinib—Dysgeusia—Methotrexate—germ cell cancer	0.000284	0.00114	CcSEcCtD
Bosutinib—Asthenia—Etoposide—germ cell cancer	0.000283	0.00113	CcSEcCtD
Bosutinib—Back pain—Methotrexate—germ cell cancer	0.00028	0.00112	CcSEcCtD
Bosutinib—Pruritus—Etoposide—germ cell cancer	0.000279	0.00112	CcSEcCtD
Bosutinib—Vomiting—Cisplatin—germ cell cancer	0.000274	0.0011	CcSEcCtD
Bosutinib—Rash—Cisplatin—germ cell cancer	0.000272	0.00109	CcSEcCtD
Bosutinib—Dermatitis—Cisplatin—germ cell cancer	0.000272	0.00109	CcSEcCtD
Bosutinib—Diarrhoea—Etoposide—germ cell cancer	0.00027	0.00108	CcSEcCtD
Bosutinib—Ill-defined disorder—Methotrexate—germ cell cancer	0.000269	0.00108	CcSEcCtD
Bosutinib—Anaemia—Methotrexate—germ cell cancer	0.000268	0.00107	CcSEcCtD
Bosutinib—Malaise—Methotrexate—germ cell cancer	0.000261	0.00105	CcSEcCtD
Bosutinib—Dizziness—Etoposide—germ cell cancer	0.000261	0.00105	CcSEcCtD
Bosutinib—Leukopenia—Methotrexate—germ cell cancer	0.000259	0.00104	CcSEcCtD
Bosutinib—Nausea—Cisplatin—germ cell cancer	0.000256	0.00103	CcSEcCtD
Bosutinib—Cough—Methotrexate—germ cell cancer	0.000253	0.00101	CcSEcCtD
Bosutinib—Vomiting—Etoposide—germ cell cancer	0.000251	0.00101	CcSEcCtD
Bosutinib—Rash—Etoposide—germ cell cancer	0.000249	0.000997	CcSEcCtD
Bosutinib—Dermatitis—Etoposide—germ cell cancer	0.000249	0.000996	CcSEcCtD
Bosutinib—Headache—Etoposide—germ cell cancer	0.000247	0.000991	CcSEcCtD
Bosutinib—Myalgia—Methotrexate—germ cell cancer	0.000247	0.000988	CcSEcCtD
Bosutinib—Arthralgia—Methotrexate—germ cell cancer	0.000247	0.000988	CcSEcCtD
Bosutinib—Chest pain—Methotrexate—germ cell cancer	0.000247	0.000988	CcSEcCtD
Bosutinib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000245	0.000981	CcSEcCtD
Bosutinib—Discomfort—Methotrexate—germ cell cancer	0.000244	0.000976	CcSEcCtD
Bosutinib—Anaphylactic shock—Methotrexate—germ cell cancer	0.000237	0.000947	CcSEcCtD
Bosutinib—Infection—Methotrexate—germ cell cancer	0.000235	0.000941	CcSEcCtD
Bosutinib—Nausea—Etoposide—germ cell cancer	0.000235	0.000939	CcSEcCtD
Bosutinib—Nervous system disorder—Methotrexate—germ cell cancer	0.000232	0.000929	CcSEcCtD
Bosutinib—Thrombocytopenia—Methotrexate—germ cell cancer	0.000232	0.000927	CcSEcCtD
Bosutinib—Skin disorder—Methotrexate—germ cell cancer	0.00023	0.00092	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000216	0.000863	CcSEcCtD
Bosutinib—Dyspnoea—Methotrexate—germ cell cancer	0.000211	0.000845	CcSEcCtD
Bosutinib—Decreased appetite—Methotrexate—germ cell cancer	0.000206	0.000823	CcSEcCtD
Bosutinib—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000204	0.000818	CcSEcCtD
Bosutinib—Fatigue—Methotrexate—germ cell cancer	0.000204	0.000817	CcSEcCtD
Bosutinib—Pain—Methotrexate—germ cell cancer	0.000202	0.00081	CcSEcCtD
Bosutinib—Feeling abnormal—Methotrexate—germ cell cancer	0.000195	0.000781	CcSEcCtD
Bosutinib—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000193	0.000775	CcSEcCtD
Bosutinib—Urticaria—Methotrexate—germ cell cancer	0.000188	0.000753	CcSEcCtD
Bosutinib—Body temperature increased—Methotrexate—germ cell cancer	0.000187	0.000749	CcSEcCtD
Bosutinib—Abdominal pain—Methotrexate—germ cell cancer	0.000187	0.000749	CcSEcCtD
Bosutinib—MAP3K3—female gonad—germ cell cancer	0.000185	0.000473	CbGeAlD
Bosutinib—IRAK1—testis—germ cell cancer	0.000184	0.000472	CbGeAlD
Bosutinib—PDGFRB—skin of body—germ cell cancer	0.000184	0.000471	CbGeAlD
Bosutinib—TNK2—lymph node—germ cell cancer	0.000183	0.00047	CbGeAlD
Bosutinib—YES1—adrenal gland—germ cell cancer	0.000183	0.000468	CbGeAlD
Bosutinib—IRAK4—cerebellum—germ cell cancer	0.000183	0.000468	CbGeAlD
Bosutinib—SIK1—cerebellum—germ cell cancer	0.000183	0.000468	CbGeAlD
Bosutinib—PDGFRB—decidua—germ cell cancer	0.000182	0.000467	CbGeAlD
Bosutinib—ROCK1—brain—germ cell cancer	0.000182	0.000467	CbGeAlD
Bosutinib—STK10—adrenal gland—germ cell cancer	0.000181	0.000464	CbGeAlD
Bosutinib—CSF1R—gonad—germ cell cancer	0.000181	0.000464	CbGeAlD
Bosutinib—MAP2K5—pituitary gland—germ cell cancer	0.000181	0.000464	CbGeAlD
Bosutinib—MAP4K2—lymph node—germ cell cancer	0.000181	0.000464	CbGeAlD
Bosutinib—RPS6KB1—testis—germ cell cancer	0.000181	0.000463	CbGeAlD
Bosutinib—EPHA4—cerebellum—germ cell cancer	0.000181	0.000463	CbGeAlD
Bosutinib—YES1—midbrain—germ cell cancer	0.00018	0.000462	CbGeAlD
Bosutinib—TAOK3—adrenal gland—germ cell cancer	0.00018	0.000462	CbGeAlD
Bosutinib—CSF1R—uterus—germ cell cancer	0.00018	0.000461	CbGeAlD
Bosutinib—LCK—testis—germ cell cancer	0.00018	0.00046	CbGeAlD
Bosutinib—FGR—testis—germ cell cancer	0.00018	0.00046	CbGeAlD
Bosutinib—EPHB4—endocrine gland—germ cell cancer	0.000179	0.000459	CbGeAlD
Bosutinib—AXL—testis—germ cell cancer	0.000179	0.000458	CbGeAlD
Bosutinib—ERBB3—cerebellum—germ cell cancer	0.000179	0.000458	CbGeAlD
Bosutinib—STK3—lymph node—germ cell cancer	0.000178	0.000457	CbGeAlD
Bosutinib—MAP2K2—cerebellum—germ cell cancer	0.000178	0.000457	CbGeAlD
Bosutinib—ULK3—cerebellum—germ cell cancer	0.000178	0.000457	CbGeAlD
Bosutinib—TAOK3—midbrain—germ cell cancer	0.000178	0.000456	CbGeAlD
Bosutinib—MAP3K2—cerebellum—germ cell cancer	0.000177	0.000454	CbGeAlD
Bosutinib—BMPR2—brain—germ cell cancer	0.000177	0.000454	CbGeAlD
Bosutinib—YES1—bone marrow—germ cell cancer	0.000177	0.000453	CbGeAlD
Bosutinib—CSF1R—pituitary gland—germ cell cancer	0.000177	0.000453	CbGeAlD
Bosutinib—YES1—spinal cord—germ cell cancer	0.000176	0.000451	CbGeAlD
Bosutinib—EPHA2—endocrine gland—germ cell cancer	0.000176	0.000451	CbGeAlD
Bosutinib—SRC—adrenal gland—germ cell cancer	0.000176	0.00045	CbGeAlD
Bosutinib—EPHB3—brain—germ cell cancer	0.000176	0.00045	CbGeAlD
Bosutinib—STK36—brain—germ cell cancer	0.000176	0.00045	CbGeAlD
Bosutinib—FYN—endocrine gland—germ cell cancer	0.000176	0.00045	CbGeAlD
Bosutinib—MAP3K7—cerebellum—germ cell cancer	0.000176	0.00045	CbGeAlD
Bosutinib—STK10—bone marrow—germ cell cancer	0.000175	0.000449	CbGeAlD
Bosutinib—MAP2K5—medulla oblongata—germ cell cancer	0.000175	0.000448	CbGeAlD
Bosutinib—TAOK3—bone marrow—germ cell cancer	0.000175	0.000447	CbGeAlD
Bosutinib—TAOK3—spinal cord—germ cell cancer	0.000174	0.000445	CbGeAlD
Bosutinib—MERTK—brain—germ cell cancer	0.000174	0.000445	CbGeAlD
Bosutinib—EPHA2—head—germ cell cancer	0.000174	0.000445	CbGeAlD
Bosutinib—TBK1—cerebellum—germ cell cancer	0.000174	0.000445	CbGeAlD
Bosutinib—PTK2—cerebellum—germ cell cancer	0.000174	0.000445	CbGeAlD
Bosutinib—FYN—head—germ cell cancer	0.000173	0.000444	CbGeAlD
Bosutinib—SLK—testis—germ cell cancer	0.000172	0.000441	CbGeAlD
Bosutinib—MAP4K5—endocrine gland—germ cell cancer	0.000172	0.00044	CbGeAlD
Bosutinib—MAP3K3—endocrine gland—germ cell cancer	0.000172	0.00044	CbGeAlD
Bosutinib—ABL1—telencephalon—germ cell cancer	0.000172	0.00044	CbGeAlD
Bosutinib—BMPR2—lymph node—germ cell cancer	0.000171	0.000439	CbGeAlD
Bosutinib—EPHB4—testis—germ cell cancer	0.000171	0.000438	CbGeAlD
Bosutinib—CSF1R—medulla oblongata—germ cell cancer	0.00017	0.000437	CbGeAlD
Bosutinib—MAP4K4—brain—germ cell cancer	0.00017	0.000437	CbGeAlD
Bosutinib—YES1—female gonad—germ cell cancer	0.00017	0.000437	CbGeAlD
Bosutinib—IRAK1—cerebellum—germ cell cancer	0.00017	0.000436	CbGeAlD
Bosutinib—EPHB3—lymph node—germ cell cancer	0.00017	0.000435	CbGeAlD
Bosutinib—STK36—lymph node—germ cell cancer	0.00017	0.000435	CbGeAlD
Bosutinib—Asthenia—Methotrexate—germ cell cancer	0.00017	0.00068	CcSEcCtD
Bosutinib—MAP4K5—head—germ cell cancer	0.000169	0.000434	CbGeAlD
Bosutinib—MAP3K3—head—germ cell cancer	0.000169	0.000434	CbGeAlD
Bosutinib—SRC—spinal cord—germ cell cancer	0.000169	0.000434	CbGeAlD
Bosutinib—BCR—brain—germ cell cancer	0.000169	0.000434	CbGeAlD
Bosutinib—NUAK2—brain—germ cell cancer	0.000169	0.000434	CbGeAlD
Bosutinib—STK10—female gonad—germ cell cancer	0.000169	0.000433	CbGeAlD
Bosutinib—TAOK3—female gonad—germ cell cancer	0.000168	0.000431	CbGeAlD
Bosutinib—MAP3K12—brain—germ cell cancer	0.000168	0.000431	CbGeAlD
Bosutinib—MERTK—lymph node—germ cell cancer	0.000168	0.00043	CbGeAlD
Bosutinib—EPHA2—testis—germ cell cancer	0.000168	0.00043	CbGeAlD
Bosutinib—FYN—testis—germ cell cancer	0.000167	0.000429	CbGeAlD
Bosutinib—Pruritus—Methotrexate—germ cell cancer	0.000167	0.00067	CcSEcCtD
Bosutinib—RPS6KB1—cerebellum—germ cell cancer	0.000167	0.000428	CbGeAlD
Bosutinib—AXL—cerebellum—germ cell cancer	0.000165	0.000423	CbGeAlD
Bosutinib—MAP4K4—lymph node—germ cell cancer	0.000165	0.000422	CbGeAlD
Bosutinib—MAP2K1—brain—germ cell cancer	0.000165	0.000422	CbGeAlD
Bosutinib—STK35—brain—germ cell cancer	0.000165	0.000422	CbGeAlD
Bosutinib—SRC—female gonad—germ cell cancer	0.000164	0.00042	CbGeAlD
Bosutinib—ABL1—skin of body—germ cell cancer	0.000164	0.000419	CbGeAlD
Bosutinib—MAP3K3—testis—germ cell cancer	0.000164	0.000419	CbGeAlD
Bosutinib—MAP4K5—testis—germ cell cancer	0.000164	0.000419	CbGeAlD
Bosutinib—CSK—brain—germ cell cancer	0.000164	0.000419	CbGeAlD
Bosutinib—BCR—lymph node—germ cell cancer	0.000164	0.000419	CbGeAlD
Bosutinib—NUAK2—lymph node—germ cell cancer	0.000164	0.000419	CbGeAlD
Bosutinib—ABL1—decidua—germ cell cancer	0.000163	0.000417	CbGeAlD
Bosutinib—CSNK1A1—brain—germ cell cancer	0.000163	0.000416	CbGeAlD
Bosutinib—MAP3K12—lymph node—germ cell cancer	0.000162	0.000416	CbGeAlD
Bosutinib—Diarrhoea—Methotrexate—germ cell cancer	0.000162	0.000648	CcSEcCtD
Bosutinib—MAP2K5—adrenal gland—germ cell cancer	0.000162	0.000414	CbGeAlD
Bosutinib—HCK—brain—germ cell cancer	0.000161	0.000414	CbGeAlD
Bosutinib—CLK1—brain—germ cell cancer	0.000161	0.000414	CbGeAlD
Bosutinib—PDGFRB—gonad—germ cell cancer	0.000161	0.000412	CbGeAlD
Bosutinib—ABL2—brain—germ cell cancer	0.00016	0.000411	CbGeAlD
Bosutinib—MAP2K5—midbrain—germ cell cancer	0.00016	0.000409	CbGeAlD
Bosutinib—PDGFRB—uterus—germ cell cancer	0.00016	0.000409	CbGeAlD
Bosutinib—MAP2K1—lymph node—germ cell cancer	0.000159	0.000408	CbGeAlD
Bosutinib—STK35—lymph node—germ cell cancer	0.000159	0.000408	CbGeAlD
Bosutinib—SLK—cerebellum—germ cell cancer	0.000159	0.000408	CbGeAlD
Bosutinib—CAMK2G—brain—germ cell cancer	0.000158	0.000406	CbGeAlD
Bosutinib—BMP2K—brain—germ cell cancer	0.000158	0.000406	CbGeAlD
Bosutinib—YES1—endocrine gland—germ cell cancer	0.000158	0.000406	CbGeAlD
Bosutinib—CSK—lymph node—germ cell cancer	0.000158	0.000405	CbGeAlD
Bosutinib—EPHB4—cerebellum—germ cell cancer	0.000158	0.000405	CbGeAlD
Bosutinib—CSF1R—adrenal gland—germ cell cancer	0.000158	0.000404	CbGeAlD
Bosutinib—LRRK2—brain—germ cell cancer	0.000157	0.000402	CbGeAlD
Bosutinib—STK10—endocrine gland—germ cell cancer	0.000157	0.000402	CbGeAlD
Bosutinib—CSNK1A1—lymph node—germ cell cancer	0.000157	0.000402	CbGeAlD
Bosutinib—PDGFRB—pituitary gland—germ cell cancer	0.000157	0.000402	CbGeAlD
Bosutinib—EGFR—brain—germ cell cancer	0.000157	0.000401	CbGeAlD
Bosutinib—YES1—head—germ cell cancer	0.000156	0.000401	CbGeAlD
Bosutinib—Dizziness—Methotrexate—germ cell cancer	0.000156	0.000626	CcSEcCtD
Bosutinib—TAOK3—endocrine gland—germ cell cancer	0.000156	0.000401	CbGeAlD
Bosutinib—HCK—lymph node—germ cell cancer	0.000156	0.0004	CbGeAlD
Bosutinib—CLK1—lymph node—germ cell cancer	0.000156	0.0004	CbGeAlD
Bosutinib—CSF1R—midbrain—germ cell cancer	0.000156	0.000399	CbGeAlD
Bosutinib—MAP2K5—spinal cord—germ cell cancer	0.000156	0.000399	CbGeAlD
Bosutinib—ABL2—lymph node—germ cell cancer	0.000155	0.000397	CbGeAlD
Bosutinib—STK10—head—germ cell cancer	0.000155	0.000397	CbGeAlD
Bosutinib—FYN—cerebellum—germ cell cancer	0.000155	0.000396	CbGeAlD
Bosutinib—TAOK3—head—germ cell cancer	0.000154	0.000396	CbGeAlD
Bosutinib—BMP2K—lymph node—germ cell cancer	0.000153	0.000392	CbGeAlD
Bosutinib—CAMK2G—lymph node—germ cell cancer	0.000153	0.000392	CbGeAlD
Bosutinib—PTK2B—brain—germ cell cancer	0.000153	0.000392	CbGeAlD
Bosutinib—CSF1R—bone marrow—germ cell cancer	0.000153	0.000391	CbGeAlD
Bosutinib—SRC—endocrine gland—germ cell cancer	0.000152	0.000391	CbGeAlD
Bosutinib—CSF1R—spinal cord—germ cell cancer	0.000152	0.00039	CbGeAlD
Bosutinib—LRRK2—lymph node—germ cell cancer	0.000152	0.000389	CbGeAlD
Bosutinib—EGFR—lymph node—germ cell cancer	0.000151	0.000388	CbGeAlD
Bosutinib—PDGFRB—medulla oblongata—germ cell cancer	0.000151	0.000387	CbGeAlD
Bosutinib—MAP4K5—cerebellum—germ cell cancer	0.000151	0.000387	CbGeAlD
Bosutinib—MAP3K3—cerebellum—germ cell cancer	0.000151	0.000387	CbGeAlD
Bosutinib—YES1—testis—germ cell cancer	0.000151	0.000387	CbGeAlD
Bosutinib—MAP2K5—female gonad—germ cell cancer	0.000151	0.000386	CbGeAlD
Bosutinib—CSNK1E—brain—germ cell cancer	0.000151	0.000386	CbGeAlD
Bosutinib—SRC—head—germ cell cancer	0.000151	0.000386	CbGeAlD
Bosutinib—Vomiting—Methotrexate—germ cell cancer	0.00015	0.000602	CcSEcCtD
Bosutinib—STK10—testis—germ cell cancer	0.00015	0.000384	CbGeAlD
Bosutinib—TAOK3—testis—germ cell cancer	0.000149	0.000382	CbGeAlD
Bosutinib—Rash—Methotrexate—germ cell cancer	0.000149	0.000597	CcSEcCtD
Bosutinib—Dermatitis—Methotrexate—germ cell cancer	0.000149	0.000597	CcSEcCtD
Bosutinib—SIK1—brain—germ cell cancer	0.000148	0.00038	CbGeAlD
Bosutinib—IRAK4—brain—germ cell cancer	0.000148	0.00038	CbGeAlD
Bosutinib—Headache—Methotrexate—germ cell cancer	0.000148	0.000593	CcSEcCtD
Bosutinib—PTK2B—lymph node—germ cell cancer	0.000148	0.000379	CbGeAlD
Bosutinib—CSF1R—female gonad—germ cell cancer	0.000147	0.000377	CbGeAlD
Bosutinib—EPHA4—brain—germ cell cancer	0.000147	0.000376	CbGeAlD
Bosutinib—CSNK1E—lymph node—germ cell cancer	0.000146	0.000373	CbGeAlD
Bosutinib—SRC—testis—germ cell cancer	0.000145	0.000373	CbGeAlD
Bosutinib—ERBB3—brain—germ cell cancer	0.000145	0.000372	CbGeAlD
Bosutinib—MAP2K2—brain—germ cell cancer	0.000145	0.000371	CbGeAlD
Bosutinib—ULK3—brain—germ cell cancer	0.000145	0.000371	CbGeAlD
Bosutinib—MAP3K2—brain—germ cell cancer	0.000144	0.000369	CbGeAlD
Bosutinib—SIK1—lymph node—germ cell cancer	0.000143	0.000367	CbGeAlD
Bosutinib—IRAK4—lymph node—germ cell cancer	0.000143	0.000367	CbGeAlD
Bosutinib—ABL1—gonad—germ cell cancer	0.000143	0.000367	CbGeAlD
Bosutinib—MAP3K7—brain—germ cell cancer	0.000143	0.000365	CbGeAlD
Bosutinib—ABL1—uterus—germ cell cancer	0.000142	0.000364	CbGeAlD
Bosutinib—EPHA4—lymph node—germ cell cancer	0.000142	0.000363	CbGeAlD
Bosutinib—PTK2—brain—germ cell cancer	0.000141	0.000361	CbGeAlD
Bosutinib—TBK1—brain—germ cell cancer	0.000141	0.000361	CbGeAlD
Bosutinib—Nausea—Methotrexate—germ cell cancer	0.000141	0.000563	CcSEcCtD
Bosutinib—ERBB3—lymph node—germ cell cancer	0.00014	0.00036	CbGeAlD
Bosutinib—MAP2K5—endocrine gland—germ cell cancer	0.00014	0.000359	CbGeAlD
Bosutinib—MAP2K2—lymph node—germ cell cancer	0.00014	0.000359	CbGeAlD
Bosutinib—ULK3—lymph node—germ cell cancer	0.00014	0.000359	CbGeAlD
Bosutinib—PDGFRB—adrenal gland—germ cell cancer	0.00014	0.000359	CbGeAlD
Bosutinib—ABL1—pituitary gland—germ cell cancer	0.00014	0.000358	CbGeAlD
Bosutinib—YES1—cerebellum—germ cell cancer	0.00014	0.000358	CbGeAlD
Bosutinib—MAP3K2—lymph node—germ cell cancer	0.000139	0.000356	CbGeAlD
Bosutinib—MAP2K5—head—germ cell cancer	0.000138	0.000355	CbGeAlD
Bosutinib—STK10—cerebellum—germ cell cancer	0.000138	0.000354	CbGeAlD
Bosutinib—PDGFRB—midbrain—germ cell cancer	0.000138	0.000354	CbGeAlD
Bosutinib—IRAK1—brain—germ cell cancer	0.000138	0.000354	CbGeAlD
Bosutinib—TAOK3—cerebellum—germ cell cancer	0.000138	0.000353	CbGeAlD
Bosutinib—MAP3K7—lymph node—germ cell cancer	0.000138	0.000353	CbGeAlD
Bosutinib—CSF1R—endocrine gland—germ cell cancer	0.000137	0.000351	CbGeAlD
Bosutinib—TBK1—lymph node—germ cell cancer	0.000136	0.000349	CbGeAlD
Bosutinib—PTK2—lymph node—germ cell cancer	0.000136	0.000349	CbGeAlD
Bosutinib—RPS6KB1—brain—germ cell cancer	0.000136	0.000347	CbGeAlD
Bosutinib—PDGFRB—bone marrow—germ cell cancer	0.000135	0.000347	CbGeAlD
Bosutinib—CSF1R—head—germ cell cancer	0.000135	0.000346	CbGeAlD
Bosutinib—PDGFRB—spinal cord—germ cell cancer	0.000135	0.000345	CbGeAlD
Bosutinib—ABL1—medulla oblongata—germ cell cancer	0.000135	0.000345	CbGeAlD
Bosutinib—FGR—brain—germ cell cancer	0.000135	0.000345	CbGeAlD
Bosutinib—SRC—cerebellum—germ cell cancer	0.000134	0.000344	CbGeAlD
Bosutinib—AXL—brain—germ cell cancer	0.000134	0.000344	CbGeAlD
Bosutinib—MAP2K5—testis—germ cell cancer	0.000134	0.000343	CbGeAlD
Bosutinib—IRAK1—lymph node—germ cell cancer	0.000134	0.000342	CbGeAlD
Bosutinib—RPS6KB1—lymph node—germ cell cancer	0.000131	0.000336	CbGeAlD
Bosutinib—CSF1R—testis—germ cell cancer	0.000131	0.000334	CbGeAlD
Bosutinib—PDGFRB—female gonad—germ cell cancer	0.000131	0.000334	CbGeAlD
Bosutinib—FGR—lymph node—germ cell cancer	0.00013	0.000334	CbGeAlD
Bosutinib—LCK—lymph node—germ cell cancer	0.00013	0.000334	CbGeAlD
Bosutinib—AXL—lymph node—germ cell cancer	0.00013	0.000332	CbGeAlD
Bosutinib—SLK—brain—germ cell cancer	0.000129	0.000331	CbGeAlD
Bosutinib—EPHB4—brain—germ cell cancer	0.000128	0.000329	CbGeAlD
Bosutinib—EPHA2—brain—germ cell cancer	0.000126	0.000322	CbGeAlD
Bosutinib—FYN—brain—germ cell cancer	0.000126	0.000322	CbGeAlD
Bosutinib—SLK—lymph node—germ cell cancer	0.000125	0.00032	CbGeAlD
Bosutinib—ABL1—adrenal gland—germ cell cancer	0.000125	0.00032	CbGeAlD
Bosutinib—EPHB4—lymph node—germ cell cancer	0.000124	0.000318	CbGeAlD
Bosutinib—MAP2K5—cerebellum—germ cell cancer	0.000124	0.000317	CbGeAlD
Bosutinib—ABL1—midbrain—germ cell cancer	0.000123	0.000316	CbGeAlD
Bosutinib—MAP4K5—brain—germ cell cancer	0.000123	0.000315	CbGeAlD
Bosutinib—MAP3K3—brain—germ cell cancer	0.000123	0.000315	CbGeAlD
Bosutinib—EPHA2—lymph node—germ cell cancer	0.000122	0.000312	CbGeAlD
Bosutinib—PDGFRB—endocrine gland—germ cell cancer	0.000121	0.000311	CbGeAlD
Bosutinib—FYN—lymph node—germ cell cancer	0.000121	0.000311	CbGeAlD
Bosutinib—ABL1—bone marrow—germ cell cancer	0.000121	0.000309	CbGeAlD
Bosutinib—CSF1R—cerebellum—germ cell cancer	0.000121	0.000309	CbGeAlD
Bosutinib—ABL1—spinal cord—germ cell cancer	0.00012	0.000308	CbGeAlD
Bosutinib—PDGFRB—head—germ cell cancer	0.00012	0.000307	CbGeAlD
Bosutinib—MAP3K3—lymph node—germ cell cancer	0.000119	0.000304	CbGeAlD
Bosutinib—MAP4K5—lymph node—germ cell cancer	0.000119	0.000304	CbGeAlD
Bosutinib—ABL1—female gonad—germ cell cancer	0.000116	0.000298	CbGeAlD
Bosutinib—PDGFRB—testis—germ cell cancer	0.000116	0.000297	CbGeAlD
Bosutinib—YES1—brain—germ cell cancer	0.000113	0.000291	CbGeAlD
Bosutinib—STK10—brain—germ cell cancer	0.000112	0.000288	CbGeAlD
Bosutinib—TAOK3—brain—germ cell cancer	0.000112	0.000287	CbGeAlD
Bosutinib—ABCB1—blood vessel—germ cell cancer	0.00011	0.000282	CbGeAlD
Bosutinib—YES1—lymph node—germ cell cancer	0.00011	0.000281	CbGeAlD
Bosutinib—SRC—brain—germ cell cancer	0.000109	0.000279	CbGeAlD
Bosutinib—STK10—lymph node—germ cell cancer	0.000109	0.000278	CbGeAlD
Bosutinib—ABL1—endocrine gland—germ cell cancer	0.000108	0.000277	CbGeAlD
Bosutinib—TAOK3—lymph node—germ cell cancer	0.000108	0.000277	CbGeAlD
Bosutinib—PDGFRB—cerebellum—germ cell cancer	0.000107	0.000274	CbGeAlD
Bosutinib—ABL1—head—germ cell cancer	0.000107	0.000274	CbGeAlD
Bosutinib—SRC—lymph node—germ cell cancer	0.000105	0.00027	CbGeAlD
Bosutinib—ABL1—testis—germ cell cancer	0.000103	0.000264	CbGeAlD
Bosutinib—MAP2K5—brain—germ cell cancer	0.0001	0.000257	CbGeAlD
Bosutinib—CSF1R—brain—germ cell cancer	9.79e-05	0.000251	CbGeAlD
Bosutinib—MAP2K5—lymph node—germ cell cancer	9.69e-05	0.000248	CbGeAlD
Bosutinib—ABL1—cerebellum—germ cell cancer	9.53e-05	0.000244	CbGeAlD
Bosutinib—CSF1R—lymph node—germ cell cancer	9.46e-05	0.000242	CbGeAlD
Bosutinib—PDGFRB—brain—germ cell cancer	8.68e-05	0.000223	CbGeAlD
Bosutinib—PDGFRB—lymph node—germ cell cancer	8.39e-05	0.000215	CbGeAlD
Bosutinib—ABL1—brain—germ cell cancer	7.74e-05	0.000198	CbGeAlD
Bosutinib—ABL1—lymph node—germ cell cancer	7.48e-05	0.000192	CbGeAlD
Bosutinib—ABCB1—trigeminal ganglion—germ cell cancer	6.79e-05	0.000174	CbGeAlD
Bosutinib—ABCB1—embryo—germ cell cancer	6.56e-05	0.000168	CbGeAlD
Bosutinib—ABCB1—retina—germ cell cancer	5.8e-05	0.000149	CbGeAlD
Bosutinib—ABCB1—telencephalon—germ cell cancer	5.33e-05	0.000137	CbGeAlD
Bosutinib—ABCB1—decidua—germ cell cancer	5.06e-05	0.00013	CbGeAlD
Bosutinib—CYP3A4—endocrine gland—germ cell cancer	4.75e-05	0.000122	CbGeAlD
Bosutinib—ABCB1—gonad—germ cell cancer	4.45e-05	0.000114	CbGeAlD
Bosutinib—ABCB1—uterus—germ cell cancer	4.42e-05	0.000113	CbGeAlD
Bosutinib—ABCB1—pituitary gland—germ cell cancer	4.34e-05	0.000111	CbGeAlD
Bosutinib—ABCB1—medulla oblongata—germ cell cancer	4.19e-05	0.000107	CbGeAlD
Bosutinib—ABCB1—adrenal gland—germ cell cancer	3.88e-05	9.94e-05	CbGeAlD
Bosutinib—ABCB1—midbrain—germ cell cancer	3.83e-05	9.81e-05	CbGeAlD
Bosutinib—ABCB1—bone marrow—germ cell cancer	3.75e-05	9.62e-05	CbGeAlD
Bosutinib—ABCB1—spinal cord—germ cell cancer	3.74e-05	9.58e-05	CbGeAlD
Bosutinib—ABCB1—female gonad—germ cell cancer	3.62e-05	9.27e-05	CbGeAlD
Bosutinib—ABCB1—endocrine gland—germ cell cancer	3.36e-05	8.62e-05	CbGeAlD
Bosutinib—ABCB1—head—germ cell cancer	3.32e-05	8.51e-05	CbGeAlD
Bosutinib—ABCB1—testis—germ cell cancer	3.21e-05	8.22e-05	CbGeAlD
Bosutinib—ABCB1—cerebellum—germ cell cancer	2.96e-05	7.59e-05	CbGeAlD
Bosutinib—ABCB1—brain—germ cell cancer	2.41e-05	6.17e-05	CbGeAlD
Bosutinib—ABCB1—lymph node—germ cell cancer	2.33e-05	5.96e-05	CbGeAlD
Bosutinib—PDGFRB—Immune System—KIT—germ cell cancer	1.26e-05	3.6e-05	CbGpPWpGaD
Bosutinib—CSNK1E—Disease—MYC—germ cell cancer	1.26e-05	3.59e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—SLC22A3—germ cell cancer	1.26e-05	3.58e-05	CbGpPWpGaD
Bosutinib—ABCB1—Transmembrane transport of small molecules—AVP—germ cell cancer	1.26e-05	3.58e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—H2AFZ—germ cell cancer	1.25e-05	3.57e-05	CbGpPWpGaD
Bosutinib—PTK2—Innate Immune System—HRAS—germ cell cancer	1.25e-05	3.56e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—H2AFZ—germ cell cancer	1.25e-05	3.55e-05	CbGpPWpGaD
Bosutinib—EGFR—Axon guidance—HRAS—germ cell cancer	1.24e-05	3.53e-05	CbGpPWpGaD
Bosutinib—LYN—Immune System—KIT—germ cell cancer	1.24e-05	3.52e-05	CbGpPWpGaD
Bosutinib—ABL1—Immune System—KIT—germ cell cancer	1.23e-05	3.51e-05	CbGpPWpGaD
Bosutinib—YES1—Innate Immune System—HRAS—germ cell cancer	1.23e-05	3.51e-05	CbGpPWpGaD
Bosutinib—BCR—Signaling Pathways—TP53—germ cell cancer	1.23e-05	3.5e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—KITLG—germ cell cancer	1.23e-05	3.5e-05	CbGpPWpGaD
Bosutinib—BMPR2—Signaling Pathways—HRAS—germ cell cancer	1.23e-05	3.49e-05	CbGpPWpGaD
Bosutinib—CSNK1A1—Disease—HRAS—germ cell cancer	1.23e-05	3.49e-05	CbGpPWpGaD
Bosutinib—PRKCQ—Disease—HRAS—germ cell cancer	1.23e-05	3.49e-05	CbGpPWpGaD
Bosutinib—FYN—Disease—FGFR3—germ cell cancer	1.23e-05	3.49e-05	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—KIT—germ cell cancer	1.22e-05	3.48e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—FGFR3—germ cell cancer	1.22e-05	3.47e-05	CbGpPWpGaD
Bosutinib—FYN—Immune System—KIT—germ cell cancer	1.22e-05	3.47e-05	CbGpPWpGaD
Bosutinib—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	1.22e-05	3.46e-05	CbGpPWpGaD
Bosutinib—SRC—Disease—KITLG—germ cell cancer	1.21e-05	3.46e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—FGF4—germ cell cancer	1.21e-05	3.46e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—OXT—germ cell cancer	1.21e-05	3.46e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—KIT—germ cell cancer	1.21e-05	3.45e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—AVP—germ cell cancer	1.2e-05	3.42e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—KITLG—germ cell cancer	1.2e-05	3.41e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—KIT—germ cell cancer	1.2e-05	3.41e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—FGFR3—germ cell cancer	1.18e-05	3.38e-05	CbGpPWpGaD
Bosutinib—CSK—Disease—HRAS—germ cell cancer	1.18e-05	3.37e-05	CbGpPWpGaD
Bosutinib—YES1—Adaptive Immune System—HRAS—germ cell cancer	1.18e-05	3.37e-05	CbGpPWpGaD
Bosutinib—BCR—Signaling Pathways—HRAS—germ cell cancer	1.18e-05	3.35e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—KITLG—germ cell cancer	1.17e-05	3.34e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—AVP—germ cell cancer	1.17e-05	3.33e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—FGF4—germ cell cancer	1.17e-05	3.33e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—FGFR3—germ cell cancer	1.17e-05	3.33e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling by NGF—HRAS—germ cell cancer	1.17e-05	3.33e-05	CbGpPWpGaD
Bosutinib—IRAK1—Innate Immune System—HRAS—germ cell cancer	1.17e-05	3.33e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—KIT—germ cell cancer	1.17e-05	3.32e-05	CbGpPWpGaD
Bosutinib—HCK—Disease—MYC—germ cell cancer	1.16e-05	3.29e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—KITLG—germ cell cancer	1.15e-05	3.29e-05	CbGpPWpGaD
Bosutinib—TBK1—Immune System—HRAS—germ cell cancer	1.15e-05	3.27e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—KITLG—germ cell cancer	1.15e-05	3.27e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—FGFR3—germ cell cancer	1.15e-05	3.27e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—AVP—germ cell cancer	1.15e-05	3.26e-05	CbGpPWpGaD
Bosutinib—CAMK2G—Immune System—HRAS—germ cell cancer	1.13e-05	3.21e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—AVP—germ cell cancer	1.13e-05	3.21e-05	CbGpPWpGaD
Bosutinib—FYN—Disease—KIT—germ cell cancer	1.12e-05	3.2e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—AVP—germ cell cancer	1.12e-05	3.2e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—KIT—germ cell cancer	1.12e-05	3.19e-05	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—MYC—germ cell cancer	1.11e-05	3.17e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—FGFR3—germ cell cancer	1.11e-05	3.16e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—FGFR3—germ cell cancer	1.1e-05	3.15e-05	CbGpPWpGaD
Bosutinib—MAP3K3—Immune System—HRAS—germ cell cancer	1.1e-05	3.14e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Innate Immune System—HRAS—germ cell cancer	1.1e-05	3.13e-05	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—MYC—germ cell cancer	1.09e-05	3.11e-05	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—MYC—germ cell cancer	1.09e-05	3.11e-05	CbGpPWpGaD
Bosutinib—ERBB4—Disease—MYC—germ cell cancer	1.09e-05	3.1e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Developmental Biology—HRAS—germ cell cancer	1.09e-05	3.1e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—KIT—germ cell cancer	1.09e-05	3.1e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—H2AFZ—germ cell cancer	1.08e-05	3.09e-05	CbGpPWpGaD
Bosutinib—FES—Signaling Pathways—TP53—germ cell cancer	1.08e-05	3.06e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—KIT—germ cell cancer	1.07e-05	3.06e-05	CbGpPWpGaD
Bosutinib—BTK—Immune System—HRAS—germ cell cancer	1.07e-05	3.05e-05	CbGpPWpGaD
Bosutinib—LYN—Hemostasis—TP53—germ cell cancer	1.07e-05	3.04e-05	CbGpPWpGaD
Bosutinib—ABL1—Hemostasis—TP53—germ cell cancer	1.06e-05	3.02e-05	CbGpPWpGaD
Bosutinib—EGFR—Disease—FGFR3—germ cell cancer	1.06e-05	3.01e-05	CbGpPWpGaD
Bosutinib—SRC—Axon guidance—HRAS—germ cell cancer	1.06e-05	3.01e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Adaptive Immune System—HRAS—germ cell cancer	1.06e-05	3.01e-05	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—MYC—germ cell cancer	1.06e-05	3.01e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—KIT—germ cell cancer	1.05e-05	3e-05	CbGpPWpGaD
Bosutinib—FYN—Hemostasis—TP53—germ cell cancer	1.05e-05	2.99e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—H2AFZ—germ cell cancer	1.04e-05	2.98e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—FGFR3—germ cell cancer	1.04e-05	2.97e-05	CbGpPWpGaD
Bosutinib—LYN—Developmental Biology—HRAS—germ cell cancer	1.04e-05	2.96e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—FGF4—germ cell cancer	1.04e-05	2.95e-05	CbGpPWpGaD
Bosutinib—ABL1—Developmental Biology—HRAS—germ cell cancer	1.03e-05	2.95e-05	CbGpPWpGaD
Bosutinib—FES—Signaling Pathways—HRAS—germ cell cancer	1.03e-05	2.93e-05	CbGpPWpGaD
Bosutinib—IRAK4—Immune System—HRAS—germ cell cancer	1.02e-05	2.92e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—CRABP1—germ cell cancer	1.02e-05	2.92e-05	CbGpPWpGaD
Bosutinib—FYN—Developmental Biology—HRAS—germ cell cancer	1.02e-05	2.92e-05	CbGpPWpGaD
Bosutinib—LCK—Disease—FGFR3—germ cell cancer	1.02e-05	2.91e-05	CbGpPWpGaD
Bosutinib—LYN—Hemostasis—HRAS—germ cell cancer	1.02e-05	2.9e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Developmental Biology—HRAS—germ cell cancer	1.02e-05	2.9e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—KIT—germ cell cancer	1.02e-05	2.9e-05	CbGpPWpGaD
Bosutinib—ABL1—Hemostasis—HRAS—germ cell cancer	1.02e-05	2.89e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—KIT—germ cell cancer	1.01e-05	2.89e-05	CbGpPWpGaD
Bosutinib—FYN—Hemostasis—HRAS—germ cell cancer	1e-05	2.86e-05	CbGpPWpGaD
Bosutinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	9.98e-06	2.84e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—KITLG—germ cell cancer	9.97e-06	2.84e-05	CbGpPWpGaD
Bosutinib—CSNK1E—Disease—HRAS—germ cell cancer	9.9e-06	2.82e-05	CbGpPWpGaD
Bosutinib—HCK—Immune System—HRAS—germ cell cancer	9.84e-06	2.8e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—FGFR3—germ cell cancer	9.78e-06	2.79e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—AVP—germ cell cancer	9.75e-06	2.78e-05	CbGpPWpGaD
Bosutinib—EGFR—Disease—KIT—germ cell cancer	9.72e-06	2.77e-05	CbGpPWpGaD
Bosutinib—ROCK1—Signaling by GPCR—HRAS—germ cell cancer	9.63e-06	2.74e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—KITLG—germ cell cancer	9.61e-06	2.74e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Innate Immune System—HRAS—germ cell cancer	9.61e-06	2.74e-05	CbGpPWpGaD
Bosutinib—ERBB3—Disease—MYC—germ cell cancer	9.6e-06	2.74e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—KIT—germ cell cancer	9.58e-06	2.73e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—AVP—germ cell cancer	9.39e-06	2.68e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Innate Immune System—HRAS—germ cell cancer	9.38e-06	2.67e-05	CbGpPWpGaD
Bosutinib—LCK—Disease—KIT—germ cell cancer	9.36e-06	2.67e-05	CbGpPWpGaD
Bosutinib—ERBB4—Immune System—HRAS—germ cell cancer	9.27e-06	2.64e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—H2AFZ—germ cell cancer	9.25e-06	2.63e-05	CbGpPWpGaD
Bosutinib—LYN—Innate Immune System—HRAS—germ cell cancer	9.18e-06	2.62e-05	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—TP53—germ cell cancer	9.14e-06	2.6e-05	CbGpPWpGaD
Bosutinib—ABL1—Innate Immune System—HRAS—germ cell cancer	9.14e-06	2.6e-05	CbGpPWpGaD
Bosutinib—PTK2B—Immune System—HRAS—germ cell cancer	9.13e-06	2.6e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—FGFR3—germ cell cancer	9.12e-06	2.6e-05	CbGpPWpGaD
Bosutinib—HCK—Disease—HRAS—germ cell cancer	9.08e-06	2.59e-05	CbGpPWpGaD
Bosutinib—FYN—Innate Immune System—HRAS—germ cell cancer	9.04e-06	2.57e-05	CbGpPWpGaD
Bosutinib—SRC—Disease—FGFR3—germ cell cancer	9.03e-06	2.57e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Adaptive Immune System—HRAS—germ cell cancer	9e-06	2.56e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Innate Immune System—HRAS—germ cell cancer	8.99e-06	2.56e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—KIT—germ cell cancer	8.98e-06	2.56e-05	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—TP53—germ cell cancer	8.97e-06	2.56e-05	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—TP53—germ cell cancer	8.97e-06	2.56e-05	CbGpPWpGaD
Bosutinib—BLK—Immune System—HRAS—germ cell cancer	8.91e-06	2.54e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—FGFR3—germ cell cancer	8.9e-06	2.54e-05	CbGpPWpGaD
Bosutinib—FGR—Immune System—HRAS—germ cell cancer	8.88e-06	2.53e-05	CbGpPWpGaD
Bosutinib—EGFR—Developmental Biology—HRAS—germ cell cancer	8.84e-06	2.52e-05	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—MYC—germ cell cancer	8.83e-06	2.51e-05	CbGpPWpGaD
Bosutinib—LYN—Adaptive Immune System—HRAS—germ cell cancer	8.82e-06	2.51e-05	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—HRAS—germ cell cancer	8.74e-06	2.49e-05	CbGpPWpGaD
Bosutinib—LCK—Hemostasis—TP53—germ cell cancer	8.74e-06	2.49e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—FGFR3—germ cell cancer	8.71e-06	2.48e-05	CbGpPWpGaD
Bosutinib—FYN—Adaptive Immune System—HRAS—germ cell cancer	8.68e-06	2.47e-05	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—TP53—germ cell cancer	8.67e-06	2.47e-05	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—HRAS—germ cell cancer	8.58e-06	2.44e-05	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—HRAS—germ cell cancer	8.58e-06	2.44e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—FGFR3—germ cell cancer	8.58e-06	2.44e-05	CbGpPWpGaD
Bosutinib—ERBB4—Disease—HRAS—germ cell cancer	8.56e-06	2.44e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—FGFR3—germ cell cancer	8.53e-06	2.43e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—KITLG—germ cell cancer	8.51e-06	2.42e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—KIT—germ cell cancer	8.37e-06	2.39e-05	CbGpPWpGaD
Bosutinib—LCK—Hemostasis—HRAS—germ cell cancer	8.36e-06	2.38e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—AVP—germ cell cancer	8.32e-06	2.37e-05	CbGpPWpGaD
Bosutinib—SRC—Disease—KIT—germ cell cancer	8.29e-06	2.36e-05	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—HRAS—germ cell cancer	8.29e-06	2.36e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—KIT—germ cell cancer	8.17e-06	2.33e-05	CbGpPWpGaD
Bosutinib—ERBB3—Immune System—HRAS—germ cell cancer	8.17e-06	2.33e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—KIT—germ cell cancer	8e-06	2.28e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—KIT—germ cell cancer	7.88e-06	2.24e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—SLC2A3—germ cell cancer	7.86e-06	2.24e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—KIT—germ cell cancer	7.83e-06	2.23e-05	CbGpPWpGaD
Bosutinib—EGFR—Innate Immune System—HRAS—germ cell cancer	7.81e-06	2.22e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—SLC22A3—germ cell cancer	7.74e-06	2.21e-05	CbGpPWpGaD
Bosutinib—SRC—Hemostasis—TP53—germ cell cancer	7.74e-06	2.2e-05	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—MYC—germ cell cancer	7.63e-06	2.17e-05	CbGpPWpGaD
Bosutinib—SRC—Developmental Biology—HRAS—germ cell cancer	7.54e-06	2.15e-05	CbGpPWpGaD
Bosutinib—ERBB3—Disease—HRAS—germ cell cancer	7.54e-06	2.15e-05	CbGpPWpGaD
Bosutinib—LCK—Innate Immune System—HRAS—germ cell cancer	7.53e-06	2.14e-05	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—MYC—germ cell cancer	7.52e-06	2.14e-05	CbGpPWpGaD
Bosutinib—EGFR—Adaptive Immune System—HRAS—germ cell cancer	7.5e-06	2.14e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—FGFR3—germ cell cancer	7.41e-06	2.11e-05	CbGpPWpGaD
Bosutinib—SRC—Hemostasis—HRAS—germ cell cancer	7.4e-06	2.11e-05	CbGpPWpGaD
Bosutinib—PTK2—Immune System—HRAS—germ cell cancer	7.27e-06	2.07e-05	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—TP53—germ cell cancer	7.25e-06	2.06e-05	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—MYC—germ cell cancer	7.24e-06	2.06e-05	CbGpPWpGaD
Bosutinib—LCK—Adaptive Immune System—HRAS—germ cell cancer	7.23e-06	2.06e-05	CbGpPWpGaD
Bosutinib—YES1—Immune System—HRAS—germ cell cancer	7.17e-06	2.04e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—FGFR3—germ cell cancer	7.14e-06	2.03e-05	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—MYC—germ cell cancer	6.98e-06	1.99e-05	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—MYC—germ cell cancer	6.98e-06	1.99e-05	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—HRAS—germ cell cancer	6.93e-06	1.97e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—KIT—germ cell cancer	6.8e-06	1.94e-05	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—HRAS—germ cell cancer	6.8e-06	1.94e-05	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—MYC—germ cell cancer	6.73e-06	1.92e-05	CbGpPWpGaD
Bosutinib—SRC—Innate Immune System—HRAS—germ cell cancer	6.66e-06	1.9e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—MYC—germ cell cancer	6.58e-06	1.87e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—KIT—germ cell cancer	6.56e-06	1.87e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—MYC—germ cell cancer	6.42e-06	1.83e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—HRAS—germ cell cancer	6.4e-06	1.82e-05	CbGpPWpGaD
Bosutinib—SRC—Adaptive Immune System—HRAS—germ cell cancer	6.4e-06	1.82e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—FGFR3—germ cell cancer	6.32e-06	1.8e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CRABP1—germ cell cancer	6.31e-06	1.8e-05	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—TP53—germ cell cancer	6.27e-06	1.78e-05	CbGpPWpGaD
Bosutinib—FYN—Disease—MYC—germ cell cancer	6.19e-06	1.76e-05	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—TP53—germ cell cancer	6.17e-06	1.76e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—MYC—germ cell cancer	6.16e-06	1.75e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling by GPCR—HRAS—germ cell cancer	6.13e-06	1.74e-05	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—HRAS—germ cell cancer	5.99e-06	1.71e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—MYC—germ cell cancer	5.99e-06	1.71e-05	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—TP53—germ cell cancer	5.95e-06	1.69e-05	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—HRAS—germ cell cancer	5.91e-06	1.68e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—MYC—germ cell cancer	5.9e-06	1.68e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—KIT—germ cell cancer	5.81e-06	1.65e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by GPCR—HRAS—germ cell cancer	5.73e-06	1.63e-05	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—TP53—germ cell cancer	5.73e-06	1.63e-05	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—TP53—germ cell cancer	5.73e-06	1.63e-05	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—HRAS—germ cell cancer	5.69e-06	1.62e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—MYC—germ cell cancer	5.6e-06	1.59e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—HRAS—germ cell cancer	5.6e-06	1.59e-05	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—TP53—germ cell cancer	5.52e-06	1.57e-05	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—HRAS—germ cell cancer	5.48e-06	1.56e-05	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—HRAS—germ cell cancer	5.48e-06	1.56e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—HRAS—germ cell cancer	5.46e-06	1.56e-05	CbGpPWpGaD
Bosutinib—LYN—Immune System—HRAS—germ cell cancer	5.35e-06	1.52e-05	CbGpPWpGaD
Bosutinib—EGFR—Disease—MYC—germ cell cancer	5.35e-06	1.52e-05	CbGpPWpGaD
Bosutinib—ABL1—Immune System—HRAS—germ cell cancer	5.32e-06	1.52e-05	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—HRAS—germ cell cancer	5.28e-06	1.5e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—MYC—germ cell cancer	5.27e-06	1.5e-05	CbGpPWpGaD
Bosutinib—FYN—Immune System—HRAS—germ cell cancer	5.26e-06	1.5e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—HRAS—germ cell cancer	5.24e-06	1.49e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—HRAS—germ cell cancer	5.17e-06	1.47e-05	CbGpPWpGaD
Bosutinib—LCK—Disease—MYC—germ cell cancer	5.15e-06	1.47e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—HRAS—germ cell cancer	5.04e-06	1.44e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—HRAS—germ cell cancer	4.98e-06	1.42e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—TP53—germ cell cancer	4.92e-06	1.4e-05	CbGpPWpGaD
Bosutinib—FYN—Disease—HRAS—germ cell cancer	4.86e-06	1.38e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—TP53—germ cell cancer	4.85e-06	1.38e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—HRAS—germ cell cancer	4.83e-06	1.38e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—HRAS—germ cell cancer	4.7e-06	1.34e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—HRAS—germ cell cancer	4.64e-06	1.32e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—MYC—germ cell cancer	4.61e-06	1.31e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—TP53—germ cell cancer	4.6e-06	1.31e-05	CbGpPWpGaD
Bosutinib—SRC—Disease—MYC—germ cell cancer	4.56e-06	1.3e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—HRAS—germ cell cancer	4.55e-06	1.3e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—MYC—germ cell cancer	4.5e-06	1.28e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—MYC—germ cell cancer	4.4e-06	1.25e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—HRAS—germ cell cancer	4.4e-06	1.25e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—HRAS—germ cell cancer	4.38e-06	1.25e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—MYC—germ cell cancer	4.33e-06	1.23e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—TP53—germ cell cancer	4.33e-06	1.23e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—MYC—germ cell cancer	4.31e-06	1.23e-05	CbGpPWpGaD
Bosutinib—EGFR—Disease—HRAS—germ cell cancer	4.2e-06	1.2e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—HRAS—germ cell cancer	4.14e-06	1.18e-05	CbGpPWpGaD
Bosutinib—LCK—Disease—HRAS—germ cell cancer	4.05e-06	1.15e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—HRAS—germ cell cancer	3.88e-06	1.11e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—TP53—germ cell cancer	3.78e-06	1.08e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—MYC—germ cell cancer	3.74e-06	1.07e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—TP53—germ cell cancer	3.69e-06	1.05e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—HRAS—germ cell cancer	3.62e-06	1.03e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—TP53—germ cell cancer	3.62e-06	1.03e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—MYC—germ cell cancer	3.61e-06	1.03e-05	CbGpPWpGaD
Bosutinib—SRC—Disease—HRAS—germ cell cancer	3.58e-06	1.02e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—TP53—germ cell cancer	3.56e-06	1.01e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—TP53—germ cell cancer	3.54e-06	1.01e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—HRAS—germ cell cancer	3.53e-06	1.01e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—HRAS—germ cell cancer	3.46e-06	9.85e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—HRAS—germ cell cancer	3.4e-06	9.7e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—HRAS—germ cell cancer	3.39e-06	9.64e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—MYC—germ cell cancer	3.19e-06	9.1e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—TP53—germ cell cancer	3.07e-06	8.76e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—TP53—germ cell cancer	2.96e-06	8.44e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—HRAS—germ cell cancer	2.94e-06	8.38e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—HRAS—germ cell cancer	2.83e-06	8.07e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—TP53—germ cell cancer	2.62e-06	7.47e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—HRAS—germ cell cancer	2.51e-06	7.15e-06	CbGpPWpGaD
